Private section

From concept

The ScanNanoTreat Concept

A New Paradigm in Cancer Care

ScanNanoTreat introduces a breakthrough approach to the diagnosis and treatment of solid tumours. Instead of today’s fragmented cancer pathway, where imaging, diagnosis, treatment planning, and therapy happen separately, often over weeks, ScanNanoTreat brings these steps together into a single, integrated theranostic platform.

Theranostics unifies therapy and diagnostics, enabling clinicians to see and treat cancer with unprecedented precision. ScanNanoTreat takes this concept further by combining two disruptive technologies: Spectral Photon Counting CT (SPCCT) and X-ray activated Photodynamic Therapy (X-PDT). This unique integration allows tumours to be detected, characterised, and treated using one coordinated system.

Why a New Concept Is Needed

Europe faces rising cancer incidence and growing pressure on clinical workflows. Treatment pathways are often slow and expensive, with patients exposed to significant radiation across multiple imaging and therapy sessions. Healthcare systems are struggling with demand, staffing shortages, and increasing treatment costs.

ScanNanoTreat addresses these challenges directly by:

  • Shortening the full diagnosis-to-therapy cycle
  • Reducing radiation exposure by more than 30%
  • Improving treatment precision and reducing side effects
  • Lowering overall cancer care costs by up to 40%

Photo : Eric Le Roux / Université Claude Bernard Lyon 1

An Integrated Theranostic Approach

  1. 1. Advanced Imaging Through SPCCT

Spectral Photon Counting CT provides a new generation of X-ray imaging that captures finely detailed, low-energy images and distinguishes materials with much greater accuracy than conventional CT. For cancer care, this means clearer visualisation and more informed treatment decision-making.

  1. Targeted Treatment Using Nanoprobe-Triggered X-PDT

ScanNanoTreat’s specially designed gadolinium-based nanoprobes are activated by low-energy X-rays. When activated, they produce therapeutic effects that damage tumour cells with high precision while sparing surrounding healthy tissue.

  1. A Single Workflow for Both Imaging and Therapy

The true innovation lies in bringing diagnosis and therapy into one unified process. Instead of sending the patient through multiple visits, devices, or departments, clinicians can perform:

  • Tumour identification
  • Characterisation
  • Localised therapeutic activation

all within a coordinated system designed for accuracy and efficiency.